Verdiva Bio Limited raised $411M in a Series A funding led by Forbion and General Atlantic to develop innovative therapies for obesity and cardiometabolic disorders.
Amount Raised
$411 Million
Round Type
Series A
LondonBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaInvestors
Description
Verdiva Bio Limited announced its launch as a clinical-stage biopharmaceutical company with an oversubscribed Series A financing of $411M. The funding will be used to advance a portfolio of next-generation oral and injectable treatments aimed at addressing obesity and related disorders.
Quick answer
Verdiva Bio raised $411 Million in a Series A round, dated January 9, 2025. Investors: Orbimed, General Atlantic, Forbion, RA Capital Management, LYFE Capital, Lilly Asia Ventures and Logos Capital. Verdiva Bio is based in London, England, United Kingdom.
- How much did Verdiva Bio raise?
- Verdiva Bio raised $411 Million in a Series A round on January 9, 2025.
- Who invested in Verdiva Bio?
- Orbimed, General Atlantic, Forbion, RA Capital Management, LYFE Capital, Lilly Asia Ventures and Logos Capital are named as investors in this round.
- What does Verdiva Bio do?
- Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic..
- Where is Verdiva Bio based and how big is it?
- Verdiva Bio is based in London, England, United Kingdom. Fundz records about 11 employees.
- Who are the decision-makers at Verdiva Bio?
- Fundz holds 1 contact at Verdiva Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Verdiva Bio that raised within 45 days of this round, from Fundz verified event records.
- Acasti raised $15M on February 10, 2025.
- NRx Pharmaceuticals raised $3.5M (Seed) on January 27, 2025.
- Windward Bio raised $200M (Series A) on January 10, 2025.
- Os Therapies raised $6M (Post-IPO Equity) on December 31, 2024.
- Os Therapies raised $7.1M on December 31, 2024.
- Lipella Pharmaceuticals raised $2.6M (Seed) on December 23, 2024.
Who to call at Verdiva Bio, and when
A new round usually means Verdiva Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Verdiva Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Verdiva Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Verdiva Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Verdiva Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansVerdiva Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.